Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Conroy

Showing results (31-40 of 138) with videos related to

Pageof 14
Sort By:
JDR Clinical and Translational Research|March 3, 2022
Lessons Learned from the Preimplementation Phase of an Oral Health Care ProjectJ Murray, S C Hunter, Z Splawinski, et al.
La Revue De Medecine Interne|February 24, 2000
[Non-surgical treatments of esophageal cancers]T Conroy, M C Kaminsky, D Peiffert, et al.
British Journal of Industrial Medicine|October 1, 1970
Circadian excretory rhythms in night workersR T Conroy, A L Elliott, J N Mills
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Factors affecting local control and survival after treatment of carcinoma of the rectum by endocavitary radiation: a retrospective study of 97 casesP Rauch, P Bey, D Peiffert, et al.
British Journal of Cancer|June 1, 1992
Late cardiopulmonary toxicity after treatment for Hodgkin's diseaseC Allavena, T Conroy, P Aletti, et al.
Nursing Times|April 20, 2002
Heel pressure ulcers: the extent of the problemH Monaghan, S Halstead, T Conroy, et al.
Bulletin Du Cancer|January 1, 1992
[Chemotherapy of malignant ovarian Brenner tumors. Review of the literature apropos of 2 histological complete remissions after polychemotherapy]C Platini, B Weber, T Conroy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Brain metastases from epithelial ovarian carcinomaM.-C. Kaminsky-Forrett, B. Weber, T. Conroy, et al.
Bulletin Du Cancer|January 1, 1989
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease]D Peiffert, P Bey, P Lederlin, et al.
Anti-Cancer Drugs|February 1, 1995
Addition of heparin in 5-fluorouracil solution for portal vein infusion has no influence on its stability under clinically relevant conditionsM Barberi-Heyob, J L Merlin, M Vigneron, et al.
Pageof 14

Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
JDR Clinical and Translational Research|March 3, 2022
Lessons Learned from the Preimplementation Phase of an Oral Health Care ProjectJ Murray, S C Hunter, Z Splawinski, et al.
La Revue De Medecine Interne|February 24, 2000
[Non-surgical treatments of esophageal cancers]T Conroy, M C Kaminsky, D Peiffert, et al.
British Journal of Industrial Medicine|October 1, 1970
Circadian excretory rhythms in night workersR T Conroy, A L Elliott, J N Mills
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Factors affecting local control and survival after treatment of carcinoma of the rectum by endocavitary radiation: a retrospective study of 97 casesP Rauch, P Bey, D Peiffert, et al.
British Journal of Cancer|June 1, 1992
Late cardiopulmonary toxicity after treatment for Hodgkin's diseaseC Allavena, T Conroy, P Aletti, et al.
Nursing Times|April 20, 2002
Heel pressure ulcers: the extent of the problemH Monaghan, S Halstead, T Conroy, et al.
Bulletin Du Cancer|January 1, 1992
[Chemotherapy of malignant ovarian Brenner tumors. Review of the literature apropos of 2 histological complete remissions after polychemotherapy]C Platini, B Weber, T Conroy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Brain metastases from epithelial ovarian carcinomaM.-C. Kaminsky-Forrett, B. Weber, T. Conroy, et al.
Bulletin Du Cancer|January 1, 1989
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease]D Peiffert, P Bey, P Lederlin, et al.
Anti-Cancer Drugs|February 1, 1995
Addition of heparin in 5-fluorouracil solution for portal vein infusion has no influence on its stability under clinically relevant conditionsM Barberi-Heyob, J L Merlin, M Vigneron, et al.
Pageof 14